Polymer-lipid hybrid nanoparticles co-encapsulating fucoxanthin and carbon dots for targeted anti-inflammatory therapy in Alzheimer's disease
RSC Pharmaceutics · 2026 · 3 (3) · 669-681
DOI: 10.1039/d6pm00008h ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von J. Horacio Silvestre-Martínez und 3 weiteren Autor:innen. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Centro de Investigación Científica y de Educación Superior de Ensenada, Baja California.
Themen: Demenz
Abstract (Originalsprache)
Tf-functionalized hybrid NPs promote fucoxanthin and carbon dot brain targeting, creating a theranostic platform to suppress reactive astrocyte markers (GFAP, S100β, APP) via NF-κB pathway inhibition.
Förderung
- Centro de Investigación Científica y de Educación Superior de Ensenada, Baja California
Zitieren
APA
Silvestre-Martínez, J. H., Yañez-Algandar, L. G., Lugo-Ibarra, K. D. C., & Castro-Ceseña, A. B. (2026). Polymer-lipid hybrid nanoparticles co-encapsulating fucoxanthin and carbon dots for targeted anti-inflammatory therapy in Alzheimer's disease. RSC Pharmaceutics, 3(3), 669-681. https://doi.org/10.1039/d6pm00008h
Vancouver
Silvestre-Martínez JH, Yañez-Algandar LG, Lugo-Ibarra KDC, Castro-Ceseña AB. Polymer-lipid hybrid nanoparticles co-encapsulating fucoxanthin and carbon dots for targeted anti-inflammatory therapy in Alzheimer's disease. RSC Pharmaceutics. 2026;3(3):669-681. doi:10.1039/d6pm00008h
BibTeX
@article{SilvestreMartnez2026,
author = {Silvestre-Martínez, J. Horacio and Yañez-Algandar, Lorna G. and Lugo-Ibarra, Karina del Carmen and Castro-Ceseña, Ana B.},
title = {Polymer-lipid hybrid nanoparticles co-encapsulating fucoxanthin and carbon dots for targeted anti-inflammatory therapy in Alzheimer's disease},
journal = {RSC Pharmaceutics},
year = {2026},
volume = {3},
number = {3},
pages = {669--681},
doi = {10.1039/d6pm00008h}
}
EUVIMED